• New Hope for those with Melanoma

    Cancer

    October 1, 2017

    Injectable Immunotherapy Treatment Offers Promising Results

    A new kind of treatment that’s injected directly into the tumor is giving patients with metastatic melanoma another option.

    The injectable treatment, called T-VEC (talimogene laherparepvec) works in two ways: It’s designed to destroy cancer cells at the primary site to prompt the person’s immune system to find and destroy cancer cells, and it’s engineered with a protein that draws immune-boosting cells to the tumor, which boosts the drug’s cancer-killing abilities.

    “Significant strides have been made in the past few years for the treatment of advanced melanoma. It often requires the use of several methods over the person’s course of therapy,” says Anush Patel, MD, Bassett’s division chief of hematology and oncology. “This new treatment works in two different ways and offers promising results for patients with metastatic tumors.”